Pain 45
Natural health product licensed in Canada
- Other names
- Pain
- Licence holder
- Absorb Science Inc.
- NPN or DIN-HM
- 80142382
- Status
- Active licence
- Licence date
- 3 July 2025
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 2 mg | Not calculated |
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Potency : 40 % Boswellic acids | 250 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcumine | 260 mg | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 600 mg | 30 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80142382
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.